News
GSK is putting the finishing touches on its case for antibody-drug conjugate Blenrep with a key progression-free survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback